Key Highlights

  • 16 is the November 2026 date on which Stem, Inc. (NYSE:STEM) is scheduled to release third quarter results at about 4:05 p.m. ET, with the conference call at 5:00 p.m. ET after a reschedule from November 5.
  • 33.7 million USD is the Revenue Stem reported for the second quarter of 2026, down 12% from USD 38.4 million a year earlier, alongside a net loss of USD 14.4 million or USD 1.58 per share.
  • 6.2 million USD is the adjusted EBITDA for the second quarter, up 63% from USD 3.8 million, marking a fifth consecutive positive quarter, while full-year guidance of USD 10 million to USD 15 million was reaffirmed.
  • 184.0 million USD is the carrying value of convertible notes at June 30, 2026, against USD 38.4 million of cash, which frames the Balance Sheet backdrop for the third quarter report.

What Investors Expect From Stem, Inc. (NYSE:STEM) on November 16, 2026

Stem, Inc. will release its third quarter 2026 results on Monday, November 16, 2026, after the market close. The company release is expected at about 4:05 p.m. ET and the conference call begins at 5:00 p.m. ET, following a reschedule from November 5 for logistical reasons. Published market data puts the market Capitalization at roughly USD 21 million, calculated from a share price of USD 2.29 and about 9.1 million weighted average shares. For comparison, second quarter revenue was USD 33.7 million and first quarter revenue was USD 29.0 million, so first-half revenue totaled USD 62.7 million, calculated.

The Rationale: Last Reported Quarter and Management Outlook for Stem, Inc. (NYSE:STEM)

In the quarter ended June 30, 2026, revenue fell 12% to USD 33.7 million while adjusted EBITDA rose to USD 6.2 million, GAAP gross Margin was 41% and non-GAAP gross margin was 55%. Bookings reached USD 36.8 million, up 39% from USD 26.5 million, contracted Backlog rose 18% to USD 27.1 million, and annual Recurring Revenue climbed to USD 62.4 million. Management reaffirmed 2026 guidance of USD 140 million to USD 190 million in revenue, USD 10 million to USD 15 million in adjusted EBITDA, 40% to 50% non-GAAP gross margin and year-end annual recurring revenue of USD 65 million to USD 70 million.

Valuation, Liquidity and Risks for Stem, Inc. (NYSE:STEM)

Cash and equivalents were USD 38.4 million at June 30, 2026, while noncurrent convertible notes carried at USD 184.0 million and senior secured notes at USD 135.2 million total USD 319.2 million, calculated. A financing obligation adds USD 24.0 million noncurrent and USD 13.2 million current. Operating Cash Flow was USD 0.3 million in the quarter. With a market capitalization under USD 100 million, the shares are small-cap and can be volatile and thinly traded. Risks include lumpy hardware resale revenue, leverage, project timing and execution against a wide revenue guidance range.

Where Things Stand

Where things stand: Stem, Inc. (NYSE:STEM) heads into November 16, 2026 with second quarter revenue of USD 33.7 million, adjusted EBITDA of USD 6.2 million and cash of USD 38.4 million. Management reaffirmed full-year revenue guidance of USD 140 million to USD 190 million, which implies USD 77.3 million to USD 127.3 million for the second half, calculated from first-half revenue of USD 62.7 million. Bookings of USD 36.8 million, backlog of USD 27.1 million and annual recurring revenue of USD 62.4 million will be watched for continuity. The company has not changed its year-end annual recurring revenue range of USD 65 million to USD 70 million. This article is informational and is not Investment advice.